Roberto Díez-Martínez

Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain.

Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez.